We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
16 hedge funds and large institutions have $47.9M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
22% less capital invested
Capital invested by funds: $61.4M → $47.9M (-$13.5M)
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$164K |
| 2 |
BlackRock
New York
|
+$97.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$39.5K |
| 4 |
JP Morgan Chase
New York
|
+$9.73K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$9.66K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.23M |
| 2 |
Renaissance Technologies
New York
|
-$618K |
| 3 |
RA
Royce & Associates
New York
|
-$359K |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$203K |
| 5 |
Morgan Stanley
New York
|
-$53.1K |
